CliffBio
small molecule

EOVIST

GADOXETATE DISODIUM

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameEOVIST
Active ingredientGADOXETATE DISODIUM
Strength2.72145GM/15ML (181.43MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalFebruary 2013
Marketing statusRX

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.